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The LSPI-a gene of Drosophila melanogaster is located
on the X chromosome at 11B yet is not dosage compen-
sated. In order to determine if this gene is inherently
incapable of dosage compensation or if it does not
compensate because the appropriate regulatory cis-acting
sequences are absent from its chromosomal domain, we
have undertaken to relocate it to ectopic sites on the
X chromosome. To differentiate between the transcripts
produced by the transduced gene and those produced by
the indigenous gene, we inserted a 500-bp sequence of
mouse DNA into the LSPI-a clone prior to using it for
transformation. Our results show that the LSPI-ax gene
exhibits equivalent levels of transcripts in the two sexes
when it is relocated to either an autosomal site or to an
ectopic site on the X chromosome. We conclude that the
LSPI-ct gene is capable of dosage compensation.
Key words: dosage compensation/LSPI-ca/gene relocation/
transformation
Introduction
Males and females of Drosophila melanogaster compensate
for the difference in dosage of their X-linked genes by
enhancing the transcriptional activity of most of these genes
in males (see Jaffe and Laird, 1986, and Lucchesi and
Manning, 1987, for recent reviews of the phenomenon of
dosage compensation). The ability to compensate, i.e. to
hyperactivate in a male, appears to be conferred by closely
linked cis-acting sequences. Evidence supporting this
contention derives from the relocation of cloned X-linked
genes to an autosomal site by P-element-mediated germ line
transformation (Hazelrigg et al., 1984; Levis et al., 1985;
Pirrotta et al., 1985; Krumm et al., 1985; McNabb and
Beckendorf, 1986). These transduced genes continue to
produce more product in males than in females and appear,
therefore, to be able to respond to the regulatory mechanism
of dosage compensation from their ectopic locations. In
complementary experiments, cloned autosomal genes re-
located to the X chromosome are often found to exhibit
dosage compensation, suggesting that they have come under
the influence of X-linked regulatory elements (Scholnick et
al., 1983; Spradling and Rubin, 1983; Marsh et al., 1985).
A notable exception to the general rule of dosage com-
pensation of wild-type alleles of X-linked genes is LSPI-cx,
the gene which encodes the a-subunit of the larval serum
protein 1. Whether the polypeptide itself (Roberts and
Evans-Roberts, 1979) or its RNA (Brock and Roberts, 1982)
is measured, female larvae exhibit twice the amount of gene
product found in males. This failure to compensate could
be explained by assuming that the ct-chain gene has been
translocated from an autosome to the X chromosome
relatively recently during the course of the evolution of the
genus and has not yet developed the means to respond to
the compensatory mechanism. Furthermore, there may exist
little selective pressure for compensation because the gene's
product is interchangeable with that of two autosomal genes
encoding very similar larval serum protein 1 subunits,
LSPJ-f3 and LSPI-'y (Roberts and Evans-Roberts, 1979).
During the course of a study of the role of hypersensitive
sites on the regulation of LSP genes, Jowett (1985) stated
that, in four instances of P-element-mediated transposition
of a cloned LSPI-ct gene to ectopic sites including one on
the X chromosome, no dosage compensation was shown by
any of the insertions.
The absence of dosage compensation of a wild-type
X-linked gene could be due to an inherent property of the
gene itself. The kinetics of polymerase binding and of
initiation of transcription may be such that the promoter
region of a particular gene is rapidly saturated upon
activation. The transcription of such a gene would not be
amenable to enhancement and the level of product would
be dependent on gene dosage. In order to determine if
LSPJ-ct is inherently incapable of dosage compensation or
if it does not compensate because the appropriate regulatory
cis-acting sequences are absent from its chromosomal
domain, we have undertaken to relocate this gene to ectopic
sites on the X chromosome. To differentiate between the
transcripts produced by the transduced gene and those
produced by the indigenous gene, we inserted a 500 bp
sequence of mouse DNA into the LSPI-ct clone prior to using
it for transformation. This hybrid gene produced a longer
transcript, easily separable from the normal transcript by
electrophoresis. Our results show that the steady-state levels
of transcripts of the LSPJ-ot gene relocated to ectopic sites
on the X chromosome are equivalent in males (one dose)
and females (two doses) and that this gene is, therefore,
capable of dosage compensation.
Results
Construction of the transformation vector and
recovery of transformants
A 500 bp BamHI fragment of coding sequence from the
mouse L1 repeat was inserted into one of the two 3'-most
BamHl sites of the LSPI-ce gene (Figure IA). This hybrid
gene was introduced as a 9.9 kb EcoRl insert into the
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Fig. 1. (A) Schematic diagram of the LSPI-oe clone showing the
restriction sites of interest (R, EcoRI; H, HindIII; B, BamHI). For a
more complete restriction map, see Brock and Roberts (1983). The
solid line represents Drosophila genomic DNA; the open boxes are the
coding regions of LSPI-a; the stippled region is vector DNA. For
construction of the pELBA transformation vector, the B1O mouse
DNA fragment was inserted into one of the two HindIII sites indicated
by asterisks. The HindIII fragment used as a probe is indicated by the




Fig. 3. Examples of in situ hybridization of a biotinylated Hindill
probe to larval salivary gland polytene chromosomes. The double
arrows indicate the site of the indigenous LSPI-ce gene at 11A and the
single arrows indicate the site of insertion of LSPI-oaBJO at 19F in
transformant line G44 (A) and at 13DE in transformant line F53 (B).
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Fig. 2. Northern blot analysis of total RNA derived from third instar
larvae from a wild-type (CS) strain and from two autosomal
transformant lines. (A) The blot was probed with the 32P-labeled
HindIII fragment containing LSPI-ae coding sequences. Note the
presence of a larger RNA species in the transformants. (B) The same
blot following removal of the HindIII probe and hybridization to a
32P-labeled B1O probe.
pPA-1 transformation vector which contains P-element
sequences required for transposition and an Adh+ gene for
positive selection of transformants. The new construct,
designated pELBA, is diagrammed in Figure lB. Germline
transformations were performed, following the methods and
procedures of Rubin and Spradling (1982, 1983) and Karess
Fig. 4. Determination of the relative steady-state level of LSPI-ceBJO
A+ RNA, Sgs-3 A+ RNA and rp49 A+ RNA in adult males and
females of transformant line F53. Hybridization of the Northern blot
was with 32P-labeled BlO DNA, Sgs-3 DNA and rp49 DNA. Lane
a, 1.7 Ieg male RNA; lane b, 0.85 ug male RNA; lane c, 1.74 tig
female RNA; lane d, 0.87 teg female RNA. The areas of the blot
containing the hybridizing bands were excised and the radioactivity
determined. The results are shown in Table I.
and Rubin (1984), by injecting the pELBA vector and the
plasmid helper pir25.7wc into preblastoderm embryos.
Transformants were selected among the progeny of G1
individuals by positive selection on ethanol. A total of 1459
embryos were injected yielding 480 adults (33% survival)
which produced 21 independent transformation events
(4.8 %). For those transformants that were homozygous and
fertile, permanent lines (a total of eight) were established
















The LSP1-a gene of Drosophila melanogaster
Molecular and cytological characterization of
transformant lines
The LSPI-ct gene is normally active during the third larval
instar, leading to a maximum level of steady-state RNA a
few hours before pupariation; this level declines slightly as
the larvae pupariate (Powell et al., 1984). During the period
of peak RNA synthesis, the LSPJ-cx transcript can be readily
detected by dot-blot hybridization in total nucleic acid
preparations from dissected larval fat bodies (Brock and
Roberts, 1982). To determine if the transduced LSPJ-cxBJO
hybrid gene in transformant lines produced transcripts which
could be differentiated from that of the indigenous gene and
which were of sufficient stability and abundance to be
quantified, total RNA was extracted from late third instar
larvae and size fractionated by electrophoresis. Northern
blots of this RNA, probed with the 6.0 kb HindIll fragment
Table I. Analysis of steady-state levels of LSPJ-cxBlO transcripts in
males and females of transformant line F53
RNA c.p.m. hybridizeda- Ratio in males
(utg) male
BlO Sgs-3 rp49 BlO BlO Sgs-3
Sgs-3 rp49 rp49
1.70 7189 9574 5662 0.75 1.27 1.70
0.85 3061 4316 2548 0.71 1.20 1.70
c.p.m. hybridized- Ratio in female Male/female
female
BlO Sgs-3 rp49 BIO B10 Sgs-3 B1O B10 Sgs-3
Sgs-3 rp49 rp49 Sgs-3 rp49 rp49
1.74 6997 9009 6055 0.77 1.16 1.49 0.97 1.09 1.14
0.87 3011 4955 3057 0.61 0.99 1.62 1.16 1.21 1.05
aRespective areas of the Northern blot of transformant line F53
showing hybridization in Figure 4 were excised and radioactivity
determined. Nylon membrane of an equivalent area was excised where
no hybridization was observed and counted to determine background
radioactivity. 32P-Labeled probes used were: BJO, 500 bp BamHI LI
BJO mouse fragment; Sgs-3, 5.7 kb EcoRI fragment from cDM2008;
rp49, 639 bp EcoRI-HindIII fragment from pGRP49.
shown in Figure IA, revealed a major band of hybridization
at 2.85 kb, corresponding to the native LSPJ-c RNA (Smith
et al., 1981), and a second less intense band at 3.3 kb (Figure
2). Since the latter band is seen only in RNA from
transformed individuals and is the sole hybridization product
observed in Northern blots probed with B1O DNA, it is taken
to be the RNA transcript of the transposed LSPI-cxBJO
hybrid gene.
The location of the transduced LSPJ-aB10 hybrid genes
was determined by in situ hybridization of a biotinylated
probe consisting of the HindIII fragment shown in Figure
IA. All transformant lines exhibited hybridization at lB
on the salivary gland chromosome map, identifying the locus
of the indigenous gene (Brock and Roberts, 1983). Two lines
had an additional X-linked site (Figure 3) and the remaining
six lines an additional autosomal site. One line among the
latter was not used in this study because it included some
individuals whose glands were apparently mosaic for an
additional insertion, a phenomenon previously reported by
Krumm et al. (1985). The cytological location of the single
ectopic sites present in the seven lines studied is provided
in Table II. The intensity of the hybridization signal at these
ectopic sites and at the normal locus of the LSPI-at gene
were comparable, indicating that all insertions contained a
single copy of the transduced gene. This was consistent with
the results of Southern blot analysis of genomic DNA from
transformed lines (data not shown).
Analysis of the expression of transduced genes in
transformant lines
In order to determine if the LSPJ-aB10 gene is hyperactive
in males (i.e. is subjected to dosage compensation) when
it is inserted on the X chromosome, the steady-state level
of its transcript was measured in male and female larvae from
all of the transformant lines. An example of the approach
used for analysis of the LSPI-aiBJO transcript in the two
sexes is shown for transformant line F53 (Figure 4, Table
I). Following hybridization of Northern blots with a radio-
labeled B10 probe, the hybridizing bands corresponding to
the LSPJ-aB10 transcript were excised and the radioactivity
measured. A direct comparison of the radioactivity in the
Table II. Relative steady-state levels of LSPJ-ciBJO transcripts in males and females
LSPI-caBJO Cytological RNA c.p.m. hybridizeda male/female
insertion position preparation LSPJ-aBJO LSPI-oaBJO Sgs-3
Sgs-3 rp49 rp49
F53 13DE (X) 1 1.06 + 0.12 0.93 + 0.20 1.08 + 0.06
2 0.88 + 0.18 0.80 + 0.17 1.00 ± 0.12
G44 19F (X) 1 0.80 + 0.12 0.83 ± 0.13 1.07 + 0.25
2 0.78 + 0.14 0.87 + 0.12 1.14 + 0.23
V24 53A (2R) 1 1.09 + 0.24 1.00 ± 0.01 1.05 ± 0.14
2 1.06 ± 0.12 1.24 ± 0.06 1.18 ± 0.12
B26 59A (2R) 1 1.10 ± 0.24 1.26 ± 0.07 1.22 0.25
2 1.13 ±0.23 1.18 ±0.16 1.05 ±0.25
D21 82B (3R) 1 0.83 ± 0.05 1.06 ± 0.21 1.28 ± 0.25
2 1.07 ± 0.09 1.07 ± 0.19 0.89 ± 0.01
S13 85CD (3R) 1 0.73 ± 0.10 0.95 ± 0.12 1.32 ± 0.13
2 0.75 ± 0.13 0.74 ± 0.11 0.98 ± 0.10
B1 98C (3R) 1 0.77 ± 0.07 1.00 ± 0.06 1.28 ± 0.05
2 0.78 0.11 0.95 ±0.08 1.21 ±0.19
aPresented in the table are the means of the male-to-female ratios, obtained as described in Table I, and their standard deviations. The number of




bands showed the level of the LSPJ-atBJ0 transcripts in
the male and female larvae to be equivalent at both RNA
concentrations tested. However, since some inaccuracy in
the amounts of mRNA (i.e. the actual fraction of mRNA
in the A+ RNA preparation) loaded onto the Northern blot
is possible, an internal control to allow for correction of such
differences was provided by quantification of the steady-state
level of the RNA encoded by the autosomal salivary gland
secretion polypeptide gene Sgs-3 (Korge, 1975; Beckendorf
and Kafatos, 1976; Muskavitch and Hogness, 1982) and the
ribosomal protein gene rp49 (O'Connell and Rosbash, 1984).
As shown in Table I, the ratio of the steady-state levels of
the LSPJ-aB10 transcripts and the autosomal gene transcripts
is essentially identical, again indicating that the level of the
LSPJ-aB10 transcripts in the two sexes is equivalent. An
additional parameter to assess the accuracy of this method
of quantification is provided by the measurement of the
autosomal gene transcripts, since the male-to-female ratio
of Sgs-3/rp49 transcripts should be - 1.0 in all transformant
lines.
The results of this analysis, presented in Figure 4 and
Tables I and II, indicate that in four out of five cases where
the LSPI-ctBJO gene is autosomal, there is no difference in
the steady-state level of the LSPJ-oB10 transcript between
males and females. Although in one of these four trans-
formant lines (BI) the LSPJ-atB10/Sgs-3 ratio is significantly
< 1.0 (0.78) while the LSPJ-aB10/rp49 ratio is - 1.0, it
should be noted that in both RNA samples the Sgs-3/rp49
ratio is > 1.0. This indicates that the Sgs-3 transcript is more
abundant in these RNA samples than the rp49 transcript,
an imbalance which would result in an LSPJ-cxB10/Sgs-3
ratio of < 1.0. In one transformant line with an autosomal
insert (S 13), females clearly had higher levels of gene
Table III. Dosage effects on steady-state levels of LSPI-aBJO
transcripts in females
Line Heterozygous/homozygous femalesa nb
F53 0.64 4 0.08 4
G44 0.51 + 0.07 3
B26 0.58 + 0.18 2
aMean male-to-female ratios of the counts hybridized to LSPI-aIBJO
RNA relative to Sgs-3 RNA and their standard errors. Hybridization
probes are as described in Table I.
Number of independent RNA extractions.
product than males. In comparison, one transformant line
(F53) with an X-linked transduced gene exhibits equal levels
of transcripts in males and females, while the second X-
linked transformant line (G44) shows that females have
-20-25% higher levels of transcripts than males. Since
in these two lines males carry a single dose and females carry
two doses of the transduced gene, it is legitimate to conclude
that the single dose in males is compensated.
To rule out the possibility that the hyperactivation of the
single dose of the X-linked LSPI-aBJO is due, for some
reason, to its unpaired condition in males, homozygous
females were compared with females bearing a single dose
of the transduced gene. The results, presented in Table III,
show an - 50% reduction in gene product in heterozygous
females and are consistent with the expected dosage response
of a single X-linked gene within a female.
Discussion
The fundamental aspect of the mechanism of dosage
compensation is the ability of most X-linked genes to achieve
equal levels of products in males and females by enhancing
the transcriptional activity of the single dose in males. It is
not sufficient for one X-linked gene or a small cluster of
genes to be present in single dose in order to be dosage
compensated. There must exist a substantial deviation from
the ratio of X chromosomes to sets of autosomes (X/A)
before enhancement of activity can occur. While Maroni and
Lucchesi (1980) have shown that this deviation can be
fractional, in nature it usually consists of the absence of an
entire X chromosome in males. It is therefore reasonable
to contend that such programmed regulation of transcription
must involve the interaction of trans-acting factors with
X-linked cis-acting sequences. The observation that cloned
autosomal genes relocated to the X chromosome are often
compensated suggests that the X-linked cis-acting regulatory
sequences responsible for enhancement of gene activity in
males are widely distributed.
The LSPI-ce gene of D. melanogaster, although normally
present on the X chromosome, is not dosage compensated.
The primary purpose of the experiments reported in this
paper was to determine if this gene is inherently incapable
of responding to the compensatory mechanism. Were this
not the case, one may reasonably conclude that LSPI-a is
not compensated because it happens to reside outside of
Fig. 5. Examples of the Northern blots used to quantify the relative steady-state level of LSPI-czBJO A+ RNA in transformant lines. Amounts of
A+ RNA electrophoresed were 1.5-2.0 /ag/lane. Hybridization and quantitation of radioactivity was as described in Figure 4 and Table I. The





The LSP1-cr gene of Drosophila melanogaster
the influence of the regulatory sequences responsible for
enhancing the transcription of X-linked genes in males. The
data strongly favor this latter explanation.
Of some considerable interest is the fact that one of the
LSPJ-ctB10 transformants (line G44), as well as several
autosomal genes which have been transposed to the X
chromosome, show only partial dosage compensation. An
explanation for this occurrence may be found in a general
consideration of dosage compensation as it is exhibited by
normal X-linked genes at their indigenous location. It is well
known that there exist differences in the strength of the
gene promoters, i.e. variations in their ability to initiate
transcription. Given the great variety of genes present on
the X chromosome, it is reasonable to assume that their
promoters represent a spectrum of different strengths. Yet,
dosage compensation leads almost invariably to a rather
precise 2-fold increase in activity of X-linked genes in males.
This uniform level of enhancement may require a differential
set of interactions between promoters and compensatory
sequences. These sequences may be similar to traditional
enhancers, or they may consist of specific short sequences
(such as the one proposed by Jaffe and Laird, 1986) or of
poly(dC -dA/dG -dT) stretches (proposed by Huijser et al.,
1987; Pardue et al., 1987). Regardless of their nature, the
number of compensatory sequences and their position in
relation to a given X-linked gene must be such that a 2-fold
enhancement of that gene is achieved in males. In order to
achieve this precise level of compensation, it is likely that
considerable differences may be found in the number and
spatial relationship of compensatory sequences and the genes
which they influence. It also follows that the distribution of
these sequences along the X chromosome would be non-
random. Given such a non-random distribution of regulatory
sequences, a cloned non-dosage compensated X-linked or
autosomal gene relocated to the X chromosome may fail
to become compensated or may exhibit a wide range of
hyperactivation in males. For example, transposition of a
gene to a position on the X chromosome that fortuitously
places it under the influence of a distant compensatory
sequence may result in 'undercompensation' of the gene in
males. It might be expected, therefore, that excessive, normal
or partial compensation, as in the case of line G44, will
depend on the nature of the gene's promoter and its
interaction with the compensatory sequence(s) present in the
ectopic chromosomal domain.
Materials and methods
Tagging of the LSPl-a gene and construction of the
transformation vector
The LSPJ-cr gene, contained in a 9.4 kb EcoRI genomic fragment cloned
in pBR322 (Smith et al., 1981), was the generous gift of Dr David Glover,
B10 is a 500 bp BamHI fragment of coding sequence from the mouse LI
repeat (Martin et al., 1984) kindly provided by Dr Sandy Martin. The
LSPI-cx clone was partially digested with BamHI to produce linear molecules
and the linear form of the clone was isolated from a 0.8% agarose gel.
Ligations were performed with T4 ligase using the linearized LSPI-o! clone
treated with calf intestinal phosphatase and purified BIG fragment. Ligation
products were used to transform HBO11 cells which were plated on ampicillin
plates (Maniatis et al., 1982).
Approximately 100 colonies were transferred and tested (Grunstein and
Hogness, 1975) for hybridization with a B10 probe. Plasmid DNA was
isolated from positive colonies and the location of the B10 insert was
determined by restriction analysis in combination with Southern blots and
hybridization to the BlO probe. This was necessitated by the presence of
five BamHI sites in the LSPI-ax sequence and one BamHI site in pBR322
into which the B10 fragment could have inserted. One clone carrying the
insert in one of the two 3'-most BamHI sites was selected and designated
LSPJ-aB10. A 9.9 kb EcoRI fragment containing this hybrid gene was
isolated and inserted into the P-element transformation vector pPA-l kindly
provided by Dr J.W.Posakony. This vector contains the P-element sequences
necessary for transposition and Adh+, the structural gene for alcohol
dehydrogenase which provides a selectable marker for successful trans-
formation. The pPA-1 plasmid vector was cut with EcoRI, treated with
phosphatase, mixed with purified 9.9 kb fragment and ligated with T4 ligase
(Maniatis et al., 1982). Following transfection and plating of HB10I cells,
colonies which hybridized to a B10 probe were selected. Plasmid DNA
was isolated and subjected to restriction analysis to determine the orientation
of the LSPI-crBlO insertion. One clone was chosen and designated pELBA.
Drosophila transformation and selection of transformants
Pre-blastoderm embryos of genotype AdhFn6, cn/AdhFn6 cn; o 0l06
were injected, following the procedure of Rubin and Spradling (1982, 1983)
and Karess and Rubin (1984), with pELBA DNA (300 Ag/ml) and helper
plasmid p7r25.7wc DNA (80 ,ug/ml). Injected embryos (GO) were reared
to adulthood and mated to individuals from the same strain. Their adult
progeny (G1) were tested for the presence of transformants by positive
selection with ethanol by the procedure of Vigue and Sofer (1976) modified
by Goldberg (1980). Homozygous lines were established by inbreeding and
tested for homozygosis by outcrossing to the recipient strain.
In situ hybridization to polytene chromosomes
A HindIll subfragment of the cloned LSPI-as gene was labeled with a
biotinylated nucleotide by nick-translation and allowed to hybridize to its
homologous sequences on larval salivary gland polytene chromosomes; its
presence was detected by the binding of a streptavidin -biotin-horseradish
peroxidase complex (ENZO Biochem Inc.) according to a method modified
by E.Hafen (personal communication).
RNA blot analysis
Late third instar larvae were classified according to sex using the size of
the gonad anlagen as criterion. Total RNA was extracted from samples of
50 individuals as described in Levy and Manning (1982). RNA gels were
prepared according to Thomas (1980) and Southern blots according to
Southern (1975). Blots were hybridized with 32P-labeled probes which
consisted of the HindIH fragment of the cloned LSPJ-as gene, or of a mixture
of the BIO fragment, a 5.7 kb EcoRI fragment from XcDM2008 containing
the Sgs-3 sequence (Meyerowitz and Hogness, 1982), and a 639 bp
EcoRI-HindIII fragment from pGRP49 containing the rp49 sequence
(O'Connell and Rosbash, 1984). Following hybridization and autoradi-
ography, appropriate regions of the filter were cut out, using the exposed
film as a template, and their radioactivity counted. The ratio of counts
hybridized to LSPJ-arBJ0 RNA to counts hybridized to Sgs-3 and rp49 RNA
was calculated for each sample and used in the comparison of the relative
level of expression of the transduced hybrid gene between males and females
(Tables I and II).
Acknowledgements
We are grateful to Dr David Glover for his gift of the LSPI-a clone, to
Dr Sandra Martin for the mouse LI B10 fragment, to Dr Lawrence Marsh
for the pGRP49 clone and to Dr J.W.Posakony for his gift of the pPA-1
transformation vector and for advice on the ethanol-selection procedure.
This research was supported by a grant from the NIH (GM15691).
References
Beckendorf,S.K. and Kafatos,F.C. (1976) Cell, 9, 365-373.
Brock,H.W. and Roberts,D.A. (1982) Biochem. Genet., 20, 287-295.
Brock,H.W. and Roberts,D.A. (1983) Genetics, 103, 75-92.
Goldberg,D.A. (1980) Proc. Natl. Acad. Sci. USA, 77, 5794-5798.
Grunstein,M. and Hogness,D. (1975) Proc. Natl. Acad. Sci. USA, 72,
3961 -3965,
Hazelrigg,T., Levis,R. and Rubin,G.M. (1984) Cell, 36, 469-481.
Huijser,P., Hennig,W. and Dijkhof,R. (1987) Chromosoma, 95, 209-215.
Jaffe,E. and Laird,C. (1986) Trends Genet., 2, 316-321.
Jowett,T. (1985) EMBO J., 4, 3789-3795.
Karess,R.E. and Rubin,G.M. (1984) Cell, 38, 135-146.
Korge,G. (1975) Proc. Natl. Acad. Sci. USA, 72, 4550-4554.
Krumm,A., Roth,G.E. and Korge,G. (1985) Proc. Natl. Acad. Sci. USA,
82, 5055-5059.
Levis,R., Hazelrigg,T. and Rubin,G.M. (1985) EMBO J., 4, 3489-3499.
Levy,L.S. and Manning,J.E. (1982) Dev. Biol., 94, 465-476.
Lucchesi,J.C. and Manning,J.E. (1987) Adv. Genet., 24, 371-429.
1195
S.Ghosh et al.
McNabb,S.L. and Beckendorf,S.K. (1986) EMBO J., 5, 2331-2340.
Maniatis,T., Fritsch,E.F. and Sambrook,J. (1982) Molecular Cloning. A
Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring
Harbor, NY.
Maroni,G. and Lucchesi,J.C. (1980) Chromosoma, 77, 253-261.
Martin,S.L., Voliva,C.F., Burton,F.H., Edgell,M.H. and Hutchison,C.W.,
III (1984) Proc. Natl. Acad. Sci. USA, 72, 3961-3965.
Marsh,J.L., Gibbs,P.D.L. and Timmons,P.M. (1985) Mol. Gen. Genet.,
198, 393-403.
Meyerowitz,E.M. and Hogness,D.S. (1982) Cell, 28, 165-176.
Muskavitch,M.A.T. and Hogness,D.S. (1982) Cell, 29, 1041-1051.
O'Connell,P. and Rosbash,M. (1984) Nucleic Acids Res., 12, 5497-5513.
Pardue,M.L., Lowenhaupt,K., Rich,A. and Nordheim,A. (1987) EMBO
J., 6, 1781-1789.
Pirrotta,V., Steller,H. and Bozzetti,M.P. (1985) EMBO J., 4, 3501-3508.
Powell,D., Sato,J.D., Brock,H.W. and Roberts,D.B. (1984) Dev. Biol.,
102, 206-215.
Roberts,D.B. and Evans-Roberts,S. (1979) Nature, 280, 691-692.
Rubin,G.M. and Spradling,A.C. (1982) Science, 218, 348-353.
Rubin,G.M. and Spradling,A.C. (1983) Nucleic Acids Res., 11, 6341-6351.
Scholnick,S.B., Morgan,B.A. and Hirsh,J. (1983) Cell, 34, 37-45.
Smith,D.F., McClelland,A., White,B.N., Addison,C.F. and Glover,D.M.
(1981) Cell, 23, 441-449.
Southern,E.M. (1975) J. Mol. Biol., 98, 503 - 517.
Spradling,A.C. and Rubin,G.M. (1983) Cell, 34, 47-57.
Thomas,P.S. (1980) Proc. Natl. Acad. Sci. USA, 77, 5201-5205.
Vigue,C. and Sofer,W. (1976) Biochem. Genet., 14, 127-135.
Received on December 9, 1988
1196
